2026 Investor Day
Accelerating Diagnostics. Simplifying Complexity.
On May 20, 2026 Diasorin presented the new 2026-2030 Strategic Plan, outlining its vision for strategy and commercial execution in the coming years.
Here you can find all relevant materials, both for the full event and for the individual speeches.
Full Event
Individual speeches
Molecular Diagnostics
Angelo Rago, President of Luminex
Giulia Amicarelli, VP - Global Molecular Marketing & Marketing Services
Presentation
(2.99 MB)
Interview with Dr. Morgan
Medical Director, Microbiology Professor, Pathology and Laboratory Medicine Cedars-Sinai Medical Center (Los Angeles, CA).
(67.1MB)
Keep in touch
Riccardo Fava
Corporate Vice President Communication, ESG
& Investor Relations
Diasorin S.p.A.
riccardo.fava@diasorin.com
Eugenia Ragazzo
Corporate Investor Relations & ESG Senior Analyst
Diasorin S.p.A.
eugenia.ragazzo@diasorin.com